{"id":"W3032848507","doi":"10.1200/jco.2020.38.15_suppl.3587","title":"AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor: Safety and biomarker results of a phase I monotherapy dose-escalation study in patients with advanced solid tumors.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Immunohistochemistry; Phases of clinical research; Oncology; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007431528,0.0007890287,0.0009725782,0.0002552278,0.0002211493,0.0006764061,0.0005410252,0.0007071518,0.001716438],"category_scores_gemma":[0.0004119557,0.0003125413,0.0006059729,0.0003164466,0.0004899536,0.0004625072,0.0001987519,0.001523096,0.0005151991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007371563,"about_ca_system_score_gemma":0.0006885799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001020253,"about_ca_topic_score_gemma":0.002313846,"domain_scores_codex":[0.999819,0.00007185413,0.00001061625,0.00003213114,0.00002556429,0.00004091506],"domain_scores_gemma":[0.9996033,0.00006170134,0.00008990326,0.00003240745,0.0000266204,0.0001861865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4298284,0.07504787,0.02992371,0.0006814547,0.001628553,0.0006801325,0.0007367369,0.006509126,0.2572788,0.0003541122,0.007520657,0.1898105],"study_design_scores_gemma":[0.2090859,0.7051241,0.05249467,0.00003594031,0.0007047714,0.001103518,0.0001434859,0.0043098,0.02129088,0.0002590682,0.005403866,0.00004400878],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997,0.0009692276,0.0002988922,0.000125069,0.00002145096,0.0003042594,0.0005341301,0.000061258,0.0006856467],"genre_scores_gemma":[0.9948755,0.0007260329,0.0008617326,0.0003672082,0.00004316786,0.0003376924,0.001795859,0.00002199766,0.0009708563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001716438,"threshold_uncertainty_score":0.005742073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03327003852538488,"score_gpt":0.3791147057798268,"score_spread":0.3458446672544419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}